Cubist Systematic Strategies, LLC Natera, Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

A detailed history of Cubist Systematic Strategies, LLC transactions in Natera, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 86,527 shares of NTRA stock, worth $14.1 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

86,527

Previous 116,337 25.62%

Holding current value

$14.1 Million

Previous $12.6 Million 12.71%

% of portfolio

0.07%

Previous 0.09%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$97.75 - $129.67 $2.91 Million - $3.87 Million	-29,810 Reduced 25.62%	86,527 $11 Million
Q2 2024 Aug 14, 2024	BUY	$85.28 - $112.6 $928,955 - $1.23 Million	10,893 Added 10.33%	116,337 $12.6 Million
Q1 2024 May 15, 2024	SELL	$59.21 - $92.9 $7.02 Million - $11 Million	-118,582 Reduced 52.93%	105,444 $9.64 Million
Q4 2023 Feb 14, 2024	BUY	$37.55 - $62.64 $5.42 Million - $9.03 Million	144,212 Added 180.69%	224,026 $14 Million
Q3 2023 Nov 14, 2023	SELL	$43.4 - $62.52 $1.14 Million - $1.65 Million	-26,357 Reduced 24.83%	79,814 $3.53 Million
Q2 2023 Aug 14, 2023	SELL	$47.08 - $55.16 $786,283 - $921,227	-16,701 Reduced 13.59%	106,171 $5.17 Million
Q1 2023 May 15, 2023	BUY	$36.57 - $58.29 $1.58 Million - $2.51 Million	43,104 Added 54.04%	122,872 $6.82 Million
Q4 2022 Feb 14, 2023	SELL	$34.17 - $47.91 $3.28 Million - $4.6 Million	-96,096 Reduced 54.64%	79,768 $3.2 Million
Q3 2022 Nov 14, 2022	SELL	$36.93 - $56.68 $1.66 Million - $2.55 Million	-45,003 Reduced 20.38%	175,864 $7.71 Million
Q3 2022 Nov 14, 2022	SELL	$36.93 - $56.68 $1.66 Million - $2.55 Million	-45,003 Reduced 20.38%	175,864 $7.71 Million
Q2 2022 Aug 15, 2022	SELL	$28.13 - $44.54 $4.28 Million - $6.78 Million	-152,238 Reduced 40.8%	220,867 $7.83 Million
Q1 2022 May 16, 2022	BUY	$30.32 - $91.33 $9.13 Million - $27.5 Million	300,974 Added 417.26%	373,105 $15.2 Million
Q4 2021 Feb 14, 2022	BUY	$86.26 - $119.0 $2.66 Million - $3.67 Million	30,845 Added 74.71%	72,131 $6.74 Million
Q3 2021 Nov 15, 2021	SELL	$100.17 - $126.36 $3.42 Million - $4.32 Million	-34,168 Reduced 45.28%	41,286 $4.6 Million
Q2 2021 Aug 16, 2021	BUY	$86.05 - $119.72 $3.76 Million - $5.23 Million	43,718 Added 137.76%	75,454 $8.57 Million
Q1 2021 May 17, 2021	SELL	$91.47 - $124.36 $6.28 Million - $8.54 Million	-68,699 Reduced 68.4%	31,736 $3.22 Million
Q4 2020 Feb 16, 2021	BUY	$66.66 - $111.74 $2.08 Million - $3.49 Million	31,191 Added 45.05%	100,435 $10 Million
Q3 2020 Nov 16, 2020	BUY	$45.89 - $72.67 $439,947 - $696,687	9,587 Added 16.07%	69,244 $5 Million
Q2 2020 Aug 14, 2020	BUY	$26.36 - $49.86 $1.56 Million - $2.94 Million	59,057 Added 9842.83%	59,657 $2.97 Million
Q1 2020 May 15, 2020	SELL	$17.27 - $40.17 $1.78 Million - $4.14 Million	-103,109 Reduced 99.42%	600 $18,000
Q4 2019 Feb 14, 2020	BUY	$32.1 - $40.4 $1.96 Million - $2.47 Million	61,066 Added 143.2%	103,709 $3.49 Million
Q3 2019 Nov 14, 2019	BUY	$25.38 - $34.89 $158,929 - $218,481	6,262 Added 17.21%	42,643 $1.4 Million
Q2 2019 Aug 14, 2019	BUY	$17.75 - $27.58 $199,172 - $309,475	11,221 Added 44.6%	36,381 $1 Million
Q1 2019 May 15, 2019	BUY	$11.34 - $20.62 $105,779 - $192,343	9,328 Added 58.92%	25,160 $519,000
Q4 2018 Feb 14, 2019	BUY	$12.32 - $24.38 $24,196 - $47,882	1,964 Added 14.16%	15,832 $221,000
Q3 2018 Nov 14, 2018	BUY	$18.82 - $28.96 $9,259 - $14,248	492 Added 3.68%	13,868 $332,000
Q2 2018 Aug 14, 2018	BUY	$8.79 - $19.98 $117,575 - $267,252	13,376 New	13,376 $252,000

Others Institutions Holding NTRA

# of Institutions

527

Shares Held

118M

Call Options Held

308K

Put Options Held

191K

View Full List

About Natera, Inc.

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $15.7B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

More about NTRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account

Cubist Systematic Strategies, LLC Natera, Inc. Transaction History